Home > Healthcare > Medical Devices > Diagnostic Devices > Urinalysis Market

Urinalysis Market Size

Report ID: GMI439
Published Date: Jul 2023
Report Format: PDF

Download Free Sample

Urinalysis Market Size

Urinalysis Market size was worth USD 3.8 billion in 2022 and is poised to witness 5.2% CAGR from 2023 to 2032, driven by the increasing incidence of urinary tract infections (UTIs) in developing regions along with the surging demand for better diagnostic and treatment techniques.

To get key market trends

Download Free Sample

Urinalysis has emerged widely popular as one of the most effective and safe methods of diagnosis for determining UTIs. According to the American Urological Association, about 40% to 60% of women are likely to develop a UTI at least once in their lifetimes, whereas just 12% of men are expected to suffer from them. Urinalysis constitutes several tests to examine the urine samples to determine the number of white blood cells, red blood cells, and bacteria. The growing focus on lowering the likelihood of serious problems linked with UTI at later stages will also drive the market growth.

The rising development expenses driven by the continuous improvements and automation in urinalysis may restrict the business expansion. The new technical improvements have made way for significant advancements in automated urinalysis leading to increased R&D expenditures and hampered company profitability. The surge in legal and administrative fees incurred during protection of the property rights will further add to the overall cost of progress, limiting the market growth to some extent.

Urinalysis Market Report Attributes
Report Attribute	Details
Base Year:	2022
Urinalysis Market Size in 2022:	USD 3.8 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	5.2%
2032 Value Projection:	USD 6.5 Billion
Historical Data for:	2018 to 2022
No. of Pages:	200
Tables, Charts & Figures:	276
Segments covered:	Product, Application, End-use, and Region
Growth Drivers:	Increasing incidence of urinary tract infection in developing regions Increasing prevalence of chronic kidney disease worldwide Increasing geriatric population High pregnancy rates
Pitfalls & Challenges:	Low awareness about routine check-ups High R&D cost of developing instruments

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Urinalysis industry was valued at USD 3.8 billion in 2022 and is expected to exhibit 5.2% CAGR from 2023 to 2032 owing to the increasing demand for better diagnostic and treatment techniques to treat the rising incidence rate of urinary tract infections globally.

Urinalysis industry size from the consumables product segment amassed USD 2.7 billion in 2022 and is poised to expand at 4.6% CAGR from 2023-2032 owing to the growing technological improvements.

North America held 36% share of the global urinalysis market in 2022 and is expected to expand at notable pace through 2032 driven by the strong presence of key market players and well-established healthcare systems.

Some of the top companies operating in the urinalysis industry are Bio-Rad Laboratories, Inc, Cardinal Health, ARKRAY Inc., ACON Laboratories, Inc., Abbott Laboratories, Sysmex Corporation, Teco Diagnostics, Erba Mannheim, Siemens Healthineers, 77 Elektronika Kft, and F.Hoffmann-La Roche Ltd.